Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Contaminated Eye Drops Return To US FDA’s View

Feb 15 2024

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA Revises Draft Guidance On Eye Drops Quality With Microbiology Topics Section

Jan 01 2024

Beauty Part Of Lumify Story For Bausch + Lomb? From Redness Relief To 'Make Eyes Look Beautiful'

Nov 01 2023

Second Indian Firm's Eye Drops Recalled In US

Nov 16 2023

‘Pervasive Contamination’ Found At Indian Eye Drop Firm Linked To Antibiotic-Resistant Infections

Nov 15 2023

Eye Drop Manufacturers Get Advice On Seeing Quality Clearly In US FDA Draft Guidance

Oct 12 2023

Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US

Feb 21 2023

Related Companies

Bausch + Lomb, Corporation

Bausch Health Companies Inc.

Additional Topics

International India Asia Pacific United States Canada OTC Drugs Warning Letters Recalls Commercial Companies Compliance Consumer Enforcement Ingredients Manufacturing Policy Regulation Regulatory Retail Safety Ophthalmic

More from Compliance

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window